Literature DB >> 1917130

Changes in glycolipids in human renal-cell carcinoma and their clinical significance.

S Saito1, S Orikasa, C Ohyama, M Satoh, Y Fukushi.   

Abstract

The expression patterns of glycolipids of human renal-cell carcinoma were studied in primary tumors from 23 cases and 5 metastatic lesions from 4 cases using HPTLC (high-performance thin-layer chromatography). The expression pattern of glycolipids in primary tumors was characteristic of the histological cell type. In granular-cell carcinoma, lactosylceramide (CDH), GM3 and the longer-chain gangliosides (gangliosides migrating more slowly than GM3) increased, although in clear-cell carcinoma, CDH and other glycolipids tended to decrease. Globoside decreased in all cases but one, irrespective of cell type. In metastatic lesions of the clear-cell type, the prominent increase in longer-chain gangliosides was characteristic. Furthermore, the same expression pattern as that of metastastatic lesions was shown in 3 of 14 patients with primary clear-cell carcinoma, all of whom developed metastases soon after radical nephrectomy. These studies indicate that the increased expression of the longer-chain gangliosides in primary tumor is one of the factors associated with high metastatic potential, and also predict early post-operative development of metastasis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1917130     DOI: 10.1002/ijc.2910490303

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

Review 1.  Sphingolipids and expression regulation of genes in cancer.

Authors:  Gauri A Patwardhan; Yong-Yu Liu
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

2.  Olfactory mucosa response in guinea pigs following intranasal instillation with Cryptococcus neoformans. A histological and immunocytochemical study.

Authors:  C Lima; J P Vital
Journal:  Mycopathologia       Date:  1994-05       Impact factor: 2.574

3.  Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells.

Authors:  R G Uzzo; P Rayman; V Kolenko; P E Clark; M K Cathcart; T Bloom; A C Novick; R M Bukowski; T Hamilton; J H Finke
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

4.  Clustering of monosialyl-Gb5 initiates downstream signalling events leading to invasion of MCF-7 breast cancer cells.

Authors:  Severine Van Slambrouck; Wim F A Steelant
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

5.  Breast and abdominal adipose multipotent mesenchymal stromal cells and stage-specific embryonic antigen 4 expression.

Authors:  Jacquelyn R Maddox; Katherine D Ludlow; Feng Li; Christopher Niyibizi
Journal:  Cells Tissues Organs       Date:  2012-01-10       Impact factor: 2.481

6.  Chemoenzymatic Syntheses of Tumor-Associated Carbohydrate Antigen Globo-H and Stage-Specific Embryonic Antigen 4.

Authors:  Zhen Wang; Michel Gilbert; Hironobu Eguchi; Hai Yu; Jiansong Cheng; Saddam Muthana; Luyuan Zhou; Peng George Wang; Xi Chen; Xuefei Huang
Journal:  Adv Synth Catal       Date:  2008-08-04       Impact factor: 5.837

7.  Clinicopathological significance of ganglioside DSGb5 expression in renal cell carcinoma.

Authors:  Jun Itoh; Akihiro Ito; Shuichi Shimada; Yoshihide Kawasaki; Narihiko Kakoi; Hideo Saito; Koji Mitsuzuka; Mika Watanabe; Makoto Satoh; Seiichi Saito; Yoichi Arai
Journal:  Glycoconj J       Date:  2017-02-15       Impact factor: 2.916

8.  Cellular immuno-PCR. Detection of a carbohydrate tumor marker.

Authors:  Z Zhang; R F Irie; D D Chi; D S Hoon
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

9.  Monoclonal antibody (5F3) defining renal cell carcinoma-associated antigen disialosyl globopentaosylceramide (V3NeuAcIV6NeuAcGb5), and distribution pattern of the antigen in tumor and normal tissues.

Authors:  A Ito; S Saito; T Masuko; M Oh-Eda; T Matsuura; M Satoh; F M Nejad; T Enomoto; S Orikasa; S I Hakomori
Journal:  Glycoconj J       Date:  2001-06       Impact factor: 2.916

Review 10.  Re-configuration of sphingolipid metabolism by oncogenic transformation.

Authors:  Anthony S Don; Xin Y Lim; Timothy A Couttas
Journal:  Biomolecules       Date:  2014-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.